welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
no longer available

Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)

key information

study id #: NCT03433807

condition: Duchenne Muscular Dystrophy

status: no longer available


The primary objective of this Expanded Access Program is to provide idebenone as a treatment for eligible participants with Duchenne Muscular Dystrophy before it is commercially available in the United States (U.S.) for the indication of DMD.

intervention: Idebenone

mechanism of action: Antioxidant to support health

results: https://clinicaltrials.gov/ct2/show/results/NCT03433807

last updated: November 26, 2019